What is the investor’s view on Aspen Aerogels Inc (ASPN)?

While Aspen Aerogels Inc has underperformed by -1.22%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, ASPN fell by -45.37%, with highs and lows ranging from $33.15 to $4.16, whereas the simple moving average fell by -41.07% in the last 200 days.

On May 29, 2025, Barclays Downgraded Aspen Aerogels Inc (NYSE: ASPN) to Equal Weight. A report published by Oppenheimer on May 08, 2025, Downgraded its rating to ‘Perform’ for ASPN. TD Cowen also rated ASPN shares as ‘Buy’, setting a target price of $11 on the company’s shares in an initiating report dated March 07, 2025. Barclays initiated its ‘Overweight’ rating for ASPN, as published in its report on August 06, 2024. ROTH MKM’s report from March 06, 2024 suggests a price prediction of $22 for ASPN shares, giving the stock a ‘Buy’ rating. The Benchmark Company also rated the stock as ‘Buy’.

Analysis of Aspen Aerogels Inc (ASPN)

Further, the quarter-over-quarter decrease in sales is -16.70%, showing a negative trend in the upcoming months.

Aspen Aerogels Inc’s future performance can be determined with the help of several well-rounded types of analysis and research techniques, with equity being one of the most influential. The goal here is to ensure that your current return on equity of -70.97% is sufficient for you to turn a profit off your investment. Taking into account the quick ratio of the company, currently set at 3.53, you can see that the company can cover any debts it may have, which can easily be seen in the annual report of the company.

The average volume for any stock is also a very valuable indicator of volatility, and ASPN has an average volume of 1.87M. On a monthly basis, the volatility of the stock is set at 5.65%, whereas on a weekly basis, it is put at 5.12%, with a loss of -7.81% over the past seven days. Furthermore, long-term investors anticipate a median target price of $9.17, showing growth from the present price of $6.49, which can serve as yet another indication of whether ASPN is worth investing in or should be passed over.

How Do You Analyze Aspen Aerogels Inc Shares?

In addition to analyzing the fundamentals, it is also important to look at how many company employees own stock. This is because the values should be in line with investors’ expectations. As such, the current holdings of company stock inside the company are set at 1.80%. This can enable you to see the extent to which executives own the company’s stock. As opposed to executive stock, institutional ownership accounts for 87.50% of the company’s shares, contributing to an indication of company value, since large shareholders may signify strength within the organization.

ASPN shares are owned by institutional investors to the tune of 87.50% at present.

Hot this week

Results from XPLR Infrastructure LP (XIFR) show risk

While XPLR Infrastructure LP has underperformed by -2.31%, investors...

Was anything positive for Ideaya Biosciences Inc (IDYA) stock last session?

While Ideaya Biosciences Inc has overperformed by 3.36%, investors...

A stock that deserves closer examination: Acadia Healthcare Company Inc (ACHC)

While Acadia Healthcare Company Inc has underperformed by -2.54%,...

Penguin Solutions Inc (PENG)’s stock chart: A technical perspective

While Penguin Solutions Inc has underperformed by -0.85%, investors...

Therealreal Inc (REAL)’s stock performance: a year in review

While Therealreal Inc has overperformed by 2.35%, investors are...

Topics

Results from XPLR Infrastructure LP (XIFR) show risk

While XPLR Infrastructure LP has underperformed by -2.31%, investors...

Was anything positive for Ideaya Biosciences Inc (IDYA) stock last session?

While Ideaya Biosciences Inc has overperformed by 3.36%, investors...

A stock that deserves closer examination: Acadia Healthcare Company Inc (ACHC)

While Acadia Healthcare Company Inc has underperformed by -2.54%,...

Penguin Solutions Inc (PENG)’s stock chart: A technical perspective

While Penguin Solutions Inc has underperformed by -0.85%, investors...

Therealreal Inc (REAL)’s stock performance: a year in review

While Therealreal Inc has overperformed by 2.35%, investors are...

Sable Offshore Corp (SOC)’s stock price in review: A technical analysis

While Sable Offshore Corp has underperformed by -0.90%, investors...

A closer look at Voyager Therapeutics Inc (VYGR)’s stock price trends

While Voyager Therapeutics Inc has overperformed by 6.34%, investors...

Shuttle Pharmaceuticals Holdings Inc (SHPH)’s stock decline to 3.91 per share

While Shuttle Pharmaceuticals Holdings Inc has underperformed by -16.81%,...
spot_img

Related Articles

Popular Categories

spot_imgspot_img
US Post News
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.